who should avoid glp-1 medications Infographic TrimRX | GLP-1 vs. Other

Kaufman: Hyaluronic acid (HA) dermal fillers (used by 81% of HCPs) and botulinum neurotoxins (used by 69%) are leading choices because they directly address the core aesthetic changes associated with GLP-1 weight loss

With the tri-agonist medications, we're seeing even more weight loss in a shorter amount of time," Dr

PlexusDx integrates genetic and biomarker context into precision-guided therapy, empowering both patients and providers to make data-informed decisions about non-weight-focused GLP-1 access

2006 Oct;7(10):936-45

Although a fairly large proportion of patients have reported a number of side effects, particularly at the gastrointestinal level (nausea, vomiting, diarrhoea), these side effects tend to diminish over time and adherence to treatment remains high, with about 5% of patients discontinuing treatment due to side effects

With celebrity attention, positive clinical trials, and even more versions in the FDA approval pipeline, expect to see continued consumer demand